| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |